Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-04-07

Clinical Trial Update: Pharmacokinetics of Atazanavir/Ritonavir in HIV-1 Infected Pregnant Women [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study of atazanavir/ritonavir in HIV-1 infected pregnant women completed; results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Norvir (ritonavir)
  • REYATAZ (atazanavir)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: HIV Infection | Phase 1 | Status: COMPLETED | Results posted: 2011-04-07